WHO ICTRP trial
Comparison of Insulin Glargine and Detemir on Hormone Factors Affecting Appetite…
IRCT20191208045651N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20191208045651N1 |
|---|---|
| Public title | Comparison of Insulin Glargine and Detemir on Hormone Factors Affecting Appetite in Patients with Type 1 Diabetes |
| Scientific title | Comparison of Insulin Glargine and Detemir on Hormone Factors Affecting Appetite in Patients with Type 1 Diabetes |
| Primary sponsor | Iran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Type 1 Diabetes. Type 1 Diabetes mellitus |
| Interventions | Intervention 1: Intervention group 1: Includes new cases of type 1 diabetes that hospitalized. In this group, samples (n=21) received insulin Glargine for 3 months. Insulin Glargine was given to the patients once a day, subcutaneous… |
| Registration date | Dec 23, 2019 |
| Target size | 41 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: